×
About 2,148 results

ALLMedicine™ Paracentesis Center

Research & Reviews  653 results

Acute Kidney Injury in Patients with Liver Disease.
https://doi.org/10.2215/CJN.03040322
Clinical Journal of the American Society of Nephrology : ... Cullaro G, Kanduri SR et. al.

Jul 29th, 2022 - AKI is commonly encountered in patients with decompensated cirrhosis, and it is associated with unfavorable outcomes. Among factors specific to cirrhosis, hepatorenal syndrome type 1, also referred to as hepatorenal syndrome-AKI, is the most salie...

Clinical, Biochemical and Haemodynamic Effects of Large-volume Paracentesis (LVP) in Inflammatory Situations
https://clinicaltrials.gov/ct2/show/NCT02799160

Jul 26th, 2022 - Ascites is one of the common complications in advanced liver cirrhosis. Large-volume paracentesis (LVP) is a widely used symptomatic intervention to remove large amounts of peritoneal fluid. Despite a low rate of interventional-associated complica...

Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS.
https://doi.org/10.1002/hep.32676
Hepatology (Baltimore, Md.); Queck A, Schwierz L et. al.

Jul 24th, 2022 - Ascites is a definitive sign of decompensated liver cirrhosis driven by portal hypertension. Although transjugular intrahepatic portosystemic shunt insertion (TIPS) is indicated for therapy of recurrent and refractory ascites, yet there is no evid...

Trends in Procedures in the Neonatal Intensive Care Unit.
https://doi.org/10.1055/a-1905-5245
American Journal of Perinatology; Sammour I, Karnati S et. al.

Jul 21st, 2022 - Identify the rates and trends of various procedures performed on newborns. The HCUP database for the years 2002 to 2015 was queried for the number of livebirths, and various procedures using ICD-9 codes. These were adjusted to the rate of livebirt...

Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
https://clinicaltrials.gov/ct2/show/NCT00026663

Jul 18th, 2022 - Background: Ongoing research in the Molecular Pharmacology Section, NCI, requires the availability of blood, fluid, bone marrow, tumor, hair follicle and tissue samples from patients with cancer. Resistance is the underlying cause of treatment fai...

see more →

Guidelines  2 results

Guidelines on the management of ascites in cirrhosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788190
Gut Aithal GP, Palaniyappan N et. al.

Oct 18th, 2020 - The British Society of Gastroenterology in collaboration with British Association for the Study of the Liver has prepared this document. The aim of this guideline is to review and summarise the evidence that guides clinical diagnosis and managemen...

The diagnosis and management of ovarian hyperstimulation syndrome.
https://doi.org/10.1016/S1701-2163(16)35085-X
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Shmorgun D, Claman P et. al.

Nov 16th, 2011 - To review the clinical aspects of ovarian hyperstimulation syndrome and provide recommendations on its diagnosis and clinical management. These guidelines will assist in the early recognition and management of ovarian hyperstimulation. Early recog...

see more →

Drugs  9 results see all →

Clinicaltrials.gov  131 results

Clinical, Biochemical and Haemodynamic Effects of Large-volume Paracentesis (LVP) in Inflammatory Situations
https://clinicaltrials.gov/ct2/show/NCT02799160

Jul 26th, 2022 - Ascites is one of the common complications in advanced liver cirrhosis. Large-volume paracentesis (LVP) is a widely used symptomatic intervention to remove large amounts of peritoneal fluid. Despite a low rate of interventional-associated complica...

Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
https://clinicaltrials.gov/ct2/show/NCT00026663

Jul 18th, 2022 - Background: Ongoing research in the Molecular Pharmacology Section, NCI, requires the availability of blood, fluid, bone marrow, tumor, hair follicle and tissue samples from patients with cancer. Resistance is the underlying cause of treatment fai...

Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT03189108

Jul 7th, 2022 - Background: -Malignant ascites or pleural effusions are often seen in patients with solid tumor malignancies. -Malignant ascites is proinflammatory with many cytokines present and acts to promote tumor cell growth. -The cellular composition of mal...

Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes
https://clinicaltrials.gov/ct2/show/NCT03586284

Jul 6th, 2022 - Recurrent anterior uveitis in immunocompetent individuals can be caused by multiple members of the herpes virus group, including cytomegalovirus (CMV). Repeated bouts of CMV intraocular inflammation can be associated with ocular hypertension, glau...

Body Composition Changes After TIPS and Associated Clinical Outcomes
https://clinicaltrials.gov/ct2/show/NCT05420753

Jun 15th, 2022 - Sarcopenia (loss of muscle mass) and frailty (loss of muscle function) have increasingly become recognized as major prognostic factors in predicting morbidity and mortality with several disease states, including cirrhosis. Cirrhosis represents end...

see more →

News  64 results

An Academic Hospitalist–Run Outpatient Paracentesis Clinic
https://www.mdedge.com/fedprac/article/252436/hospital-medicine/academic-hospitalist-run-outpatient-paracentesis-clinic
Lawrence D. Gerber, MD, Gaetan Sgro, MD et. al.

Mar 4th, 2022 - Cirrhosis is the most common cause of ascites in the United States. In patients with compensated cirrhosis, the 10-year probability of developing ascites is 47%.

Home-Based System Relieves Refractory Ascites in Cirrhosis
https://www.medscape.com/viewarticle/964970

Dec 16th, 2021 - A home-based tunneled peritoneal catheter (PeCa) drainage system provided significant relief for patients with refractory ascites who were not candidates for transjugular intrahepatic portosystemic shunt (TIPS). For these patients, the current sta...

Home-based system relieves refractory ascites in cirrhosis
https://www.mdedge.com/internalmedicine/article/249961/hepatology/home-based-system-relieves-refractory-ascites-cirrhosis
Jim Kling

Dec 15th, 2021 - A home-based tunneled peritoneal catheter (PeCa) drainage system provided significant relief for patients with refractory ascites who were not candidates for transjugular intrahepatic portosystemic shunt (TIPS). For these patients, the current sta.

Dr. Herzog on the Optimal Use of Bevacizumab in Patients With Ovarian Cancer
https://www.onclive.com/view/dr-herzog-on-the-optimal-use-of-bevacizumab-in-patients-with-ovarian-cancer

Oct 6th, 2021 - Thomas Herzog, MD, professor of obstetrics and gynecology, deputy director, University of Cincinnati Cancer Institute, discusses the optimal use of bevacizumab (Avastin) in patients with ovarian cancer. In June 2018, the FDA approved bevacizumab ...

CDC Reports Burkholderia cepacia and B pseudomallei Outbreaks
https://www.medscape.com/viewarticle/956548

Aug 12th, 2021 - The CDC and FDA have announced an outbreak of at least 15 Burkholderia cepacia infections associated with contaminated ultrasound gel used to guide invasive procedures as well as an unrelated outbreak of Burkholderia pseudomallei that caused two d...

see more →